Rating History for Larimar Therapeutics (LRMR) by JPMorgan
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/27/2026 | Tessa Romero | New Coverage | Overweight (N/A) |
9.00 (N/A) |
3.45 (3.66) |
6.09% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/27/2026 | Tessa Romero | New Coverage | Overweight (N/A) |
9.00 (N/A) |
3.45 (3.66) |
6.09% | Details |